Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 0.52 |
| ▸ | CA9 | Q16790 | 8/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA3 | P07451 | 4/20 | 0.52 |
| ▸ | CA4 | P22748 | 4/20 | 0.52 |
| ▸ | CA6 | P23280 | 4/20 | 0.52 |
| ▸ | CA5A | P35218 | 4/20 | 0.52 |
| ▸ | CA7 | P43166 | 4/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.52 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158062 | 0.83 | CA12 (0.52) | CA12CA9MCL1CA1CA3 | |
| SCHEMBL12612153 | 0.73 | — | — | |
| Coumarin SCHEMBL6920202 | 0.71 | CA12 (0.95) | CA12CA9MCL1CA1CA3 | |
| Coumarin SCHEMBL2533286 | 0.71 | CA12 (0.95) | CA12CA9MCL1CA1CA3 | |
| Coumarin SCHEMBL30641021 | 0.71 | CA12 (0.95) | CA12CA9MCL1CA1CA3 | |
| Coumarin SCHEMBL5996993 | 0.70 | CA12 (0.91) | CA12CA9MCL1CA1CA3 | |
| SCHEMBL1091047 | 0.69 | CA12 (0.37) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL1091133 | 0.69 | MAOB (0.56) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL3441294 | 0.69 | CA12 (1.00) | CA12CA9MCL1CA1CA3 | |
| Coumarin SCHEMBL28886137 | 0.69 | CA12 (1.00) | CA12CA9MCL1CA1CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024071364-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2024-04-04 | — | — | WO | claimed |
| WO-2024058164-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-03-21 | — | — | WO | claimed |
| CN-117677669-A | Polymer composition and single layer phase difference material | 日产化学株式会社 | 2024-03-08 | — | — | CN | claimed |
| WO-2024038887-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2024-02-22 | — | — | WO | claimed |
| US-11899316-B2 | Terahertz wave control element | NAGAOKA UNIVERSITY OF TECHNOLOGY (JP) | 2024-02-13 | — | — | US | claimed |
| WO-2023171757-A1 | POLYMER COMPOSITION, SINGLE LAYER PHASE DIFFERENCE MATERIAL, AND LIQUID CRYSTAL ALIGNMENT AGENT | 日産化学株式会社 | 2023-09-14 | — | — | WO | claimed |
| CN-116601191-A | Method for producing single-layer retardation film, and polymer composition for forming single-layer retardation film | 日产化学株式会社 | 2023-08-15 | — | — | CN | claimed |
| US-20230093066-A1 | TERAHERTZ WAVE CONTROL ELEMENT | NAGAOKA UNIVERSITY OF TECHNOLOGY (JP) | 2023-03-23 | — | — | US | claimed |
| WO-2023033873-A1 | COLORED DIELECTRIC POLYMER MATERIALS AND DEVICES USING THEM | FLEXTERRA, INC. (US) | 2023-03-09 | — | — | WO | claimed |
| US-20230069886-A1 | AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE | UNIWERSYTET JAGIELLONSKI (PL) | 2023-03-09 | — | — | US | claimed |
| US-5683999-A | Cyclic urea HIV protease inhibitors | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-11-04 | — | — | US | claimed |
| EP-0752813-A4 | INHIBITORS OF METAZOAN PARASITE PROTEASES | UNIV CALIFORNIA (US) | 1997-08-20 | — | — | EP | claimed |
| US-5610192-A | Inhibitors of metazoan parasite proteases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-11 | — | — | US | claimed |
| EP-0752813-A1 | INHIBITORS OF METAZOAN PARASITE PROTEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-01-15 | — | — | EP | claimed |
| WO-1996029329-A1 | CYCLIC UREA HIV PROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-26 | — | — | WO | claimed |
| JP-H08502048-A | — | — | 1996-03-05 | — | — | JP | claimed |
| WO-1994006280-A1 | INHIBITORS OF METAZOAN PARASITE PROTEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-03-31 | — | — | WO | claimed |
| EP-0281012-B1 | 4-CHLORO-OXAZOLE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-12-11 | — | — | EP | claimed |
| US-4892799-A | PHOTOCONDUCTIVITY, ELECTROGRAPHY | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-01-09 | — | — | US | claimed |
| EP-0281012-A1 | 4-Chloro-oxazole derivatives, method for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230069886-A1 | AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE | PDIA3, PDIA5, PDIA6 | CA12 3632/4885CA9 3295/4885MCL1 925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.